CLS Holdings USA (CLSH) Stock Price, News & Analysis

Company Overview

CLS Holdings USA, Inc. is a publicly traded real estate investment and development company that specializes in the acquisition, ownership and management of commercial properties across the United States. Traded on the OTC Markets under the symbol CLSH, the company operates as a self-managed entity, integrating property and asset management functions to oversee a diversified portfolio of light industrial, manufacturing, distribution and research & development facilities.

The firm’s core activities include sourcing and underwriting single-tenant, net-leased properties to creditworthy corporate users, as well as executing build-to-suit developments and value-add repositioning projects. Through its in-house development platform, CLS Holdings USA provides site selection, design, construction management and ongoing property maintenance services. This vertically integrated approach enables the company to control costs, standardize operating procedures and enhance tenant retention for its long-term lease agreements.

Headquartered in Denver, Colorado, CLS Holdings USA was founded in 2001 and has since assembled a geographically diversified portfolio spanning major industrial markets in over 20 states. Its assets serve a broad spectrum of industries, from advanced manufacturing and logistics operations to technology and life-science research facilities. The company’s management team combines real estate investment expertise with construction and operational experience to pursue accretive acquisitions and disciplined portfolio growth across regional hubs in the Midwest, Southeast and West Coast.

Key Stats

• Today's Range: $144,200.00 to $144,200.00
• 50-Day Range: $0.04 to $144,200.00
• 52-Week Range: $0.02 to $0.07
• Volume: N/A
• Average Volume: 64,929 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CLSH Stock Analysis - Frequently Asked Questions

How have CLSH shares performed this year?

CLS Holdings USA's stock was trading at $0.0305 at the beginning of 2025. Since then, CLSH shares have increased by 472,786,785.2% and is now trading at $144,200.00.

How do I buy shares of CLS Holdings USA?

Shares of CLSH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of CLS Holdings USA own?

Based on aggregate information from My MarketBeat watchlists, some other companies that CLS Holdings USA investors own include Fulcrum Therapeutics (FULC), Kushco (KSHB), VIVUS (VVUS), iAnthus Capital (ITHUF), Aurora Cannabis (ACB), Organigram Global (OGI) and Heatwurx (PCSA).

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Retail
• Current Symbol: OTCMKTS:CLSH
• CIK: 1522222
• Web: www.clsholdingsinc.com
• Phone: (416) 992-4539
• Fax: N/A
• Employees: 75
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A